Blood-based metabolic signatures in Alzheimer's disease

INTRODUCTION: Identification of blood-based metabolic changes might provide early and easy-to-obtain biomarkers. METHODS: We included 127 Alzheimer's disease (AD) patients and 121 control subjects with cerebrospinal fluid biomarker-confirmed diagnosis (cutoff tau/amyloid β peptide 42: 0.52). Ma...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Dement (Amst)
Main Authors: de Leeuw, Francisca A., Peeters, Carel F.W., Kester, Maartje I., Harms, Amy C., Struys, Eduard A., Hankemeier, Thomas, van Vlijmen, Herman W.T., van der Lee, Sven J., van Duijn, Cornelia M., Scheltens, Philip, Demirkan, Ayşe, van de Wiel, Mark A., van der Flier, Wiesje M., Teunissen, Charlotte E.
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2017
Assuntos:
Blood-Based Biomarkers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5607205/
https://ncbi.nlm.nih.gov/pubmed/28951883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2017.07.006
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares